TNF activity and T cells

Cytokine

Volumn 101, Issue , 2018, Pages 14-18

  Mehta, Amit K ^a   Gracias, Donald T ^a   Croft, Michael ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

T cells; TNF; TNFR1; TNFR2; Treg

Indexed keywords

TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 2; TUMOR NECROSIS FACTOR RECEPTOR 1;

APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL SURVIVAL; CELLULAR IMMUNITY; CLONAL VARIATION; EFFECTOR CELL; HUMAN; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; BIOSYNTHESIS; CLASSIFICATION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INFLAMMATION; MOUSE; PHYSIOLOGY;

ANIMALS; APOPTOSIS; HUMANS; IMMUNOLOGIC MEMORY; INFLAMMATION; MICE; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84995475176     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2016.08.003     Document Type: Article

References (73)

1. Croft, M., The role of TNF superfamily members in T-cell function and diseases. Nat. Rev. Immunol. 9:4 (2009), 271–285.
2. Aggarwal, B.B., Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3:9 (2003), 745–756.
3. Clark, J., Vagenas, P., Panesar, M., Cope, A.P., What does tumour necrosis factor excess do to the immune system long term?. Ann. Rheum. Dis. 64:Suppl 4 (2005), iv70–iv76.
4. Cope, A.P., Regulation of autoimmunity by proinflammatory cytokines. Curr. Opin. Immunol. 10:6 (1998), 669–676.
5. Kollias, G., Kontoyiannis, D., Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments. Cytokine Growth Factor Rev. 13:4–5 (2002), 315–321.
6. Sfikakis, P.P., The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions. Curr. Directions Autoimmunity 11 (2010), 180–210.
7. Scheurich, P., Thoma, B., Ucer, U., Pfizenmaier, K., Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses. J. Immunol. 138:6 (1987), 1786–1790.
8. Hurme, M., Both interleukin 1 and tumor necrosis factor enhance thymocyte proliferation. Eur. J. Immunol. 18:8 (1988), 1303–1306.
9. Ranges, G.E., Zlotnik, A., Espevik, T., Dinarello, C.A., Cerami, A., Palladino, M.A. Jr., Tumor necrosis factor alpha/cachectin is a growth factor for thymocytes. Synergistic interactions with other cytokines. J. Exp. Med. 167:4 (1988), 1472–1478.
10. Yokota, S., Geppert, T.D., Lipsky, P.E., Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-alpha. J. Immunol. 140:2 (1988), 531–536.
11. Grell, M., Douni, E., Wajant, H., Lohden, M., Clauss, M., Maxeiner, B., Georgopoulos, S., Lesslauer, W., Kollias, G., Pfizenmaier, K., Scheurich, P., The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83:5 (1995), 793–802.
12. Marino, M.W., Dunn, A., Grail, D., Inglese, M., Noguchi, Y., Richards, E., Jungbluth, A., Wada, H., Moore, M., Williamson, B., Basu, S., Old, L.J., Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94:15 (1997), 8093–8098.
13. Pfeffer, K., Matsuyama, T., Kundig, T.M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P.S., Kronke, M., Mak, T.W., Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:3 (1993), 457–467.
14. Rothe, J., Lesslauer, W., Lotscher, H., Lang, Y., Koebel, P., Kontgen, F., Althage, A., Zinkernagel, R., Steinmetz, M., Bluethmann, H., Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:6440 (1993), 798–802.
15. Winsauer, C., Kruglov, A.A., Chashchina, A.A., Drutskaya, M.S., Nedospasov, S.A., Cellular sources of pathogenic and protective TNF and experimental strategies based on utilization of TNF humanized mice. Cytokine Growth Factor Rev. 25:2 (2014), 115–123.
16. Grivennikov, S.I., Tumanov, A.V., Liepinsh, D.J., Kruglov, A.A., Marakusha, B.I., Shakhov, A.N., Murakami, T., Drutskaya, L.N., Forster, I., Clausen, B.E., Tessarollo, L., Ryffel, B., Kuprash, D.V., Nedospasov, S.A., Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages/neutrophils: protective and deleterious effects. Immunity 22:1 (2005), 93–104.
17. Allie, N., Grivennikov, S.I., Keeton, R., Hsu, N.J., Bourigault, M.L., Court, N., Fremond, C., Yeremeev, V., Shebzukhov, Y., Ryffel, B., Nedospasov, S.A., Quesniaux, V.F., Jacobs, M., Prominent role for T cell-derived tumour necrosis factor for sustained control of Mycobacterium tuberculosis infection. Sci. Rep., 3, 2013, 1809.
18. Alexopoulou, L., Kranidioti, K., Xanthoulea, S., Denis, M., Kotanidou, A., Douni, E., Blackshear, P.J., Kontoyiannis, D.L., Kollias, G., Transmembrane TNF protects mutant mice against intracellular bacterial infections, chronic inflammation and autoimmunity. Eur. J. Immunol. 36:10 (2006), 2768–2780.
19. Musicki, K., Briscoe, H., Tran, S., Britton, W.J., Saunders, B.M., Differential requirements for soluble and transmembrane tumor necrosis factor in the immunological control of primary and secondary Listeria monocytogenes infection. Infect. Immun. 74:6 (2006), 3180–3189.
20. Torres, D., Janot, L., Quesniaux, V.F., Grivennikov, S.I., Maillet, I., Sedgwick, J.D., Ryffel, B., Erard, F., Membrane tumor necrosis factor confers partial protection to Listeria infection. Am. J. Pathol. 167:6 (2005), 1677–1687.
21. Cowley, S.C., Sedgwick, J.D., Elkins, K.L., Differential requirements by CD4+ and CD8+ T cells for soluble and membrane TNF in control of Francisella tularensis live vaccine strain intramacrophage growth. J. Immunol. 179:11 (2007), 7709–7719.
22. Borsotti, C., Franklin, A.R., Lu, S.X., Kim, T.D., Smith, O.M., Suh, D., King, C.G., Chow, A., Liu, C., Alpdogan, O., van den Brink, M.R., Absence of donor T-cell-derived soluble TNF decreases graft-versus-host disease without impairing graft-versus-tumor activity. Blood 110:2 (2007), 783–786.
23. Herrera, P.L., Harlan, D.M., Vassalli, P., A mouse CD8 T cell-mediated acute autoimmune diabetes independent of the perforin and Fas cytotoxic pathways: possible role of membrane TNF. Proc. Natl. Acad. Sci. U.S.A. 97:1 (2000), 279–284.
24. Cantor, J., Haskins, K., Effector function of diabetogenic CD4 Th1 T cell clones: a central role for TNF-alpha. J. Immunol. 175:11 (2005), 7738–7745.
25. Isaacs, J.D., Therapeutic T-cell manipulation in rheumatoid arthritis: past, present and future. Rheumatology 47:10 (2008), 1461–1468.
26. Probert, L., Keffer, J., Corbella, P., Cazlaris, H., Patsavoudi, E., Stephens, S., Kaslaris, E., Kioussis, D., Kollias, G., Wasting, ischemia, and lymphoid abnormalities in mice expressing T cell-targeted human tumor necrosis factor transgenes. J. Immunol. 151:4 (1993), 1894–1906.
27. Kontoyiannis, D., Pasparakis, M., Pizarro, T.T., Cominelli, F., Kollias, G., Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 10:3 (1999), 387–398.
28. Juhasz, K., Buzas, K., Duda, E., Importance of reverse signaling of the TNF superfamily in immune regulation. Expert Rev. Clin. Immunol. 9:4 (2013), 335–348.
29. Vudattu, N.K., Holler, E., Ewing, P., Schulz, U., Haffner, S., Burger, V., Kirchner, S., Andreesen, R., Eissner, G., Reverse signalling of membrane-integrated tumour necrosis factor differentially regulates alloresponses of CD4+ and CD8+ T cells against human microvascular endothelial cells. Immunology 115:4 (2005), 536–543.
30. Harashima, S., Horiuchi, T., Hatta, N., Morita, C., Higuchi, M., Sawabe, T., Tsukamoto, H., Tahira, T., Hayashi, K., Fujita, S., Niho, Y., Outside-to-inside signal through the membrane TNF-alpha induces E-selectin (CD62E) expression on activated human CD4+ T cells. J. Immunol. 166:1 (2001), 130–136.
31. Horiuchi, T., Mitoma, H., Harashima, S., Tsukamoto, H., Shimoda, T., Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents. Rheumatology 49:7 (2010), 1215–1228.
32. Mitoma, H., Horiuchi, T., Hatta, N., Tsukamoto, H., Harashima, S., Kikuchi, Y., Otsuka, J., Okamura, S., Fujita, S., Harada, M., Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha. Gastroenterology 128:2 (2005), 376–392.
33. Banerjee, D., Liou, H.C., Sen, R., C-Rel-dependent priming of naive T cells by inflammatory cytokines. Immunity 23:4 (2005), 445–458.
34. Andrews, J.S., Berger, A.E., Ware, C.F., Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma. J. Immunol. 144:7 (1990), 2582–2591.
35. Tartaglia, L.A., Weber, R.F., Figari, I.S., Reynolds, C., Palladino, M.A. Jr., Goeddel, D.V., The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. U.S.A. 88:20 (1991), 9292–9296.
36. Ware, C.F., Crowe, P.D., Vanarsdale, T.L., Andrews, J.L., Grayson, M.H., Jerzy, R., Smith, C.A., Goodwin, R.G., Tumor necrosis factor (TNF) receptor expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells. J. Immunol. 147:12 (1991), 4229–4238.
37. Aspalter, R.M., Eibl, M.M., Wolf, H.M., Regulation of TCR-mediated T cell activation by TNF-RII. J. Leukoc. Biol. 74:4 (2003), 572–582.
38. Kim, E.Y., Teh, H.S., TNF type 2 receptor (p75) lowers the threshold of T cell activation. J. Immunol. 167:12 (2001), 6812–6820.
39. Kim, E.Y., Priatel, J.J., Teh, S.J., Teh, H.S., TNF receptor type 2 (p75) functions as a costimulator for antigen-driven T cell responses in vivo. J. Immunol. 176:2 (2006), 1026–1035.
40. Calzascia, T., Pellegrini, M., Hall, H., Sabbagh, L., Ono, N., Elford, A.R., Mak, T.W., Ohashi, P.S., TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice. J. Clin. Investig. 117:12 (2007), 3833–3845.
41. Chen, X., Hamano, R., Subleski, J.J., Hurwitz, A.A., Howard, O.M., Oppenheim, J.J., Expression of costimulatory TNFR2 induces resistance of CD4+FoxP3- conventional T cells to suppression by CD4+FoxP3+ regulatory T cells. J. Immunol. 185:1 (2010), 174–182.
42. Zhang, Q., Cui, F., Fang, L., Hong, J., Zheng, B., Zhang, J.Z., TNF-alpha impairs differentiation and function of TGF-beta-induced Treg cells in autoimmune diseases through Akt and Smad3 signaling pathway. J. Mol. Cell Biol. 5:2 (2013), 85–98.
43. Lin, R.H., Hwang, Y.W., Yang, B.C., Lin, C.S., TNF receptor-2-triggered apoptosis is associated with the down-regulation of Bcl-xL on activated T cells and can be prevented by CD28 costimulation. J. Immunol. 158:2 (1997), 598–603.
44. Atreya, R., Zimmer, M., Bartsch, B., Waldner, M.J., Atreya, I., Neumann, H., Hildner, K., Hoffman, A., Kiesslich, R., Rink, A.D., Rau, T.T., Rose-John, S., Kessler, H., Schmidt, J., Neurath, M.F., Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14(+) macrophages. Gastroenterology 141:6 (2011), 2026–2038.
45. Richter, M.V., Topham, D.J., The alpha1beta1 integrin and TNF receptor II protect airway CD8+ effector T cells from apoptosis during influenza infection. J. Immunol. 179:8 (2007), 5054–5063.
46. Twu, Y.C., Gold, M.R., Teh, H.S., TNFR1 delivers pro-survival signals that are required for limiting TNFR2-dependent activation-induced cell death (AICD) in CD8+ T cells. Eur. J. Immunol. 41:2 (2011), 335–344.
47. Brenner, D., Blaser, H., Mak, T.W., Regulation of tumour necrosis factor signalling: live or let die. Nat. Rev. Immunol. 15:6 (2015), 362–374.
48. Li, X., Yang, Y., Ashwell, J.D., TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 416:6878 (2002), 345–347.
49. Suresh, M., Singh, A., Fischer, C., Role of tumor necrosis factor receptors in regulating CD8 T-cell responses during acute lymphocytic choriomeningitis virus infection. J. Virol. 79:1 (2005), 202–213.
50. Wortzman, M.E., Lin, G.H., Watts, T.H., Intrinsic TNF/TNFR2 interactions fine-tune the CD8 T cell response to respiratory influenza virus infection in mice. PLoS ONE, 8(7), 2013, e68911.
51. Ban, L., Zhang, J., Wang, L., Kuhtreiber, W., Burger, D., Faustman, D.L., Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism. Proc. Natl. Acad. Sci. U.S.A. 105:36 (2008), 13644–13649.
52. Gupta, S., Tumor necrosis factor-alpha-induced apoptosis in T cells from aged humans: a role of TNFR-I and downstream signaling molecules. Exp. Gerontol. 37:2–3 (2002), 293–299.
53. Aggarwal, S., Gollapudi, S., Gupta, S., Increased TNF-alpha-induced apoptosis in lymphocytes from aged humans: changes in TNF-alpha receptor expression and activation of caspases. J. Immunol. 162:4 (1999), 2154–2161.
54. Klein, S.A., Dobmeyer, J.M., Dobmeyer, T.S., Falke, D., Kabelitz, D., Friese, K., Helm, E.B., Hoelzer, D., Rossol-Voth, R., TNF-alpha mediated apoptosis of CD4 positive T-lymphocytes. A model of T-cell depletion in HIV infected individuals. Eur. J. Med. Res. 1:5 (1996), 249–258.
55. Gupta, S., Bi, R., Gollapudi, S., Central memory and effector memory subsets of human CD4(+) and CD8(+) T cells display differential sensitivity to TNF-{alpha}-induced apoptosis. Ann. N. Y. Acad. Sci. 1050 (2005), 108–114.
56. Lee, L.F., Lih, C.J., Huang, C.J., Cao, T., Cohen, S.N., McDevitt, H.O., Genomic expression profiling of TNF-alpha-treated BDC2.5 diabetogenic CD4+ T cells. Proc. Natl. Acad. Sci. U.S.A. 105:29 (2008), 10107–10112.
57. Chen, X., Baumel, M., Mannel, D.N., Howard, O.M., Oppenheim, J.J., Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells. J. Immunol. 179:1 (2007), 154–161.
58. Chen, X., Subleski, J.J., Hamano, R., Howard, O.M., Wiltrout, R.H., Oppenheim, J.J., Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood. Eur. J. Immunol. 40:4 (2010), 1099–1106.
59. Ehrenstein, M.R., Evans, J.G., Singh, A., Moore, S., Warnes, G., Isenberg, D.A., Mauri, C., Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J. Exp. Med. 200:3 (2004), 277–285.
60. Valencia, X., Stephens, G., Goldbach-Mansky, R., Wilson, M., Shevach, E.M., Lipsky, P.E., TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. Blood 108:1 (2006), 253–261.
61. Nie, H., Zheng, Y., Li, R., Guo, T.B., He, D., Fang, L., Liu, X., Xiao, L., Chen, X., Wan, B., Chin, Y.E., Zhang, J.Z., Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-alpha in rheumatoid arthritis. Nat. Med. 19:3 (2013), 322–328.
62. Flores-Borja, F., Jury, E.C., Mauri, C., Ehrenstein, M.R., Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis. Proc. Natl. Acad. Sci. U.S.A. 105:49 (2008), 19396–19401.
63. Nagar, M., Jacob-Hirsch, J., Vernitsky, H., Berkun, Y., Ben-Horin, S., Amariglio, N., Bank, I., Kloog, Y., Rechavi, G., Goldstein, I., TNF activates a NF-kappaB-regulated cellular program in human CD45RA- regulatory T cells that modulates their suppressive function. J. Immunol. 184:7 (2010), 3570–3581.
64. Housley, W.J., Adams, C.O., Nichols, F.C., Puddington, L., Lingenheld, E.G., Zhu, L., Rajan, T.V., Clark, R.B., Natural but not inducible regulatory T cells require TNF-alpha signaling for in vivo function. J. Immunol. 186:12 (2011), 6779–6787.
65. Chen, X., Wu, X., Zhou, Q., Howard, O.M., Netea, M.G., Oppenheim, J.J., TNFR2 is critical for the stabilization of the CD4+Foxp3+ regulatory T. cell phenotype in the inflammatory environment. J. Immunol. 190:3 (2013), 1076–1084.
66. Grinberg-Bleyer, Y., Saadoun, D., Baeyens, A., Billiard, F., Goldstein, J.D., Gregoire, S., Martin, G.H., Elhage, R., Derian, N., Carpentier, W., Marodon, G., Klatzmann, D., Piaggio, E., Salomon, B.L., Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs. J. Clin. Investig. 120:12 (2010), 4558–4568.
67. Mahmud, S.A., Manlove, L.S., Schmitz, H.M., Xing, Y., Wang, Y., Owen, D.L., Schenkel, J.M., Boomer, J.S., Green, J.M., Yagita, H., Chi, H., Hogquist, K.A., Farrar, M.A., Costimulation via the tumor-necrosis factor receptor superfamily couples TCR signal strength to the thymic differentiation of regulatory T cells. Nat. Immunol. 15:5 (2014), 473–481.
68. Faustman, D., Davis, M., TNF receptor 2 pathway: drug target for autoimmune diseases. Nat. Rev. Drug Discovery 9:6 (2010), 482–493.
69. Zhao, X., Rong, L., Zhao, X., Li, X., Liu, X., Deng, J., Wu, H., Xu, X., Erben, U., Wu, P., Syrbe, U., Sieper, J., Qin, Z., TNF signaling drives myeloid-derived suppressor cell accumulation. J. Clin. Investig. 122:11 (2012), 4094–4104.
70. Chopra, M., Riedel, S.S., Biehl, M., Krieger, S., von Krosigk, V., Bauerlein, C.A., Brede, C., Jordan Garrote, A.L., Kraus, S., Schafer, V., Ritz, M., Mattenheimer, K., Degla, A., Mottok, A., Einsele, H., Wajant, H., Beilhack, A., Tumor necrosis factor receptor 2-dependent homeostasis of regulatory T cells as a player in TNF-induced experimental metastasis. Carcinogenesis 34:6 (2013), 1296–1303.
71. Govindaraj, C., Scalzo-Inguanti, K., Madondo, M., Hallo, J., Flanagan, K., Quinn, M., Plebanski, M., Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+ Tregs within the tumor microenvironment. Clin. Immunol. 149:1 (2013), 97–110.
72. Chang, L.Y., Lin, Y.C., Chiang, J.M., Mahalingam, J., Su, S.H., Huang, C.T., Chen, W.T., Huang, C.H., Jeng, W.J., Chen, Y.C., Lin, S.M., Sheen, I.S., Lin, C.Y., Blockade of TNF-alpha signaling benefits cancer therapy by suppressing effector regulatory T cell expansion. Oncoimmunology, 4(10), 2015, e1040215.
73. Croft, M., The TNF family in T cell differentiation and function–unanswered questions and future directions. Semin. Immunol. 26:3 (2014), 183–190.